Your browser doesn't support javascript.
loading
Changes in liver steatosis in HIV-positive women are associated with the BMI, but not with biomarkers.
Fernandez-Botran, Rafael; Plankey, Michael W; Ware, Deanna; Bordon, José.
Afiliação
  • Fernandez-Botran R; Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY, United States. Electronic address: rafael@louisville.edu.
  • Plankey MW; Division of Infectious Diseases, Department of Medicine, Georgetown University, Washington, District of Columbia, United States.
  • Ware D; Division of Infectious Diseases, Department of Medicine, Georgetown University, Washington, District of Columbia, United States.
  • Bordon J; George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States.
Cytokine ; 144: 155573, 2021 08.
Article em En | MEDLINE | ID: mdl-33994069
ABSTRACT
The prevalence of non-alcoholic fatty liver disease (NAFLD) is higher in HIV-infected patients compared to the general population. While metabolic risk factors such as obesity, insulin resistance and the metabolic syndrome have been identified as key risk factors in all individuals, there is limited information regarding the mechanisms that contribute to the higher prevalence among individuals living with HIV, particularly among women and ethnic minorities. The aim of this study was to determine the association, over two time points, of a panel of biomarkers with liver steatosis in a cohort of HIV-seropositive women and age-matched negative controls and to investigate whether the association differed by HIV status. To this effect, plasma samples obtained from 105 HIV-positive and -negative participants enrolled in the Women's Interagency HIV study (WIHS) Washington DC site were assayed for biomarkers associated with inflammation, adipose tissue function, fibrinolysis, gut permeability and hepatocyte apoptosis/necrosis. Their association with liver steatosis, measured using Controlled-Attenuation Parameter (CAP) scores determined by transient elastography, were then analyzed. HIV positivity was associated with lower median IL-17A and higher IL-22 and sCD14 values. There were no statistically significant associations between HIV status, biomarkers or covariates with CAP measurement over two time points. However, IL-1ß levels were associated with higher CAP scores at the second visit. Across all statistical models, an increase in BMI was associated with an increase in CAP measurements. No statistically significant associations were found between viral load history, CD4 + T-cell count, biomarkers and covariates, including ART use, on CAP measurements. These results confirm that BMI is a key risk factor for liver steatosis independent of HIV status. The potential contributions to NAFLD of differences in IL-1ß, Th17-family cytokines and gut permeability between HIV-positive vs. negative individuals require further study.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Infecções por HIV / Fígado Gorduroso / Fígado Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Cytokine Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Infecções por HIV / Fígado Gorduroso / Fígado Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Cytokine Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article